Estabrook Capital Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Estabrook Capital Management's OGN Position: Q2 2026 in Review
Estabrook Capital Management increased its Organon & Co (OGN) stake by 81% in Q2 2026, buying an estimated $717 and bringing the position to 134 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #324.
Estabrook Capital Management first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $221K in Q2 2021. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Estabrook Capital Management held 134 shares of Organon & Co worth $1.81K as of Q2 2026.
- Estabrook Capital Management bought 60 Organon & Co shares in Q2 2026, an estimated $717.
- Organon & Co made up ﹤0.01% of Estabrook Capital Management's portfolio in Q2 2026, its #324 holding.
- Estabrook Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Estabrook Capital Management's Organon & Co position peaked at $221K in Q2 2021.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Estabrook Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.